Biotechnology & genetic engineering reviews, Vol. 38, Issue 2, Pages 339-383, 2022

PMID: 35968863

Tissue biopsy analysis has conventionally been the gold standard for cancer prognosis, diagnosis and prediction of responses/resistances to treatments. The existing biopsy procedures used in clinical practice are, however, invasive, painful and often associated with pitfalls like poor recovery of tumor cells and infeasibility for repetition in single patients.

Read More

  https://www.ncbi.nlm.nih.gov/pubmed/35968863